2,4,6-trinitrotoluene (TNT) - OEHHA
2,4,6-trinitrotoluene (TNT) - OEHHA
2,4,6-trinitrotoluene (TNT) - OEHHA
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1<br />
2,4,6-Trinitrotoluene (<strong>TNT</strong>)<br />
CAS No. 118-96-7<br />
Formula: C6H2(NO2) 3CH3 MW: 227.1<br />
Chemical Class: polynitroaromatic hydrocarbon<br />
Office of Environmental Health Hazard Assessment
2<br />
Use & Occurrence of <strong>TNT</strong><br />
• Explosives in military & industrial applications<br />
(munitions, coal/mineral mining, deep well/<br />
underwater blasting, building demolitions)<br />
• Chemical intermediate<br />
• In soil & surface/ground water near sites of use<br />
Office of Environmental Health Hazard Assessment
3<br />
Carcinogenicity Studies of <strong>TNT</strong><br />
• Studies in humans<br />
—One ecologic study<br />
—One case-control study<br />
—One cohort study<br />
—Several case reports<br />
• Studies in animals<br />
— Two-year dietary studies in rats of both sexes<br />
— Two-year dietary studies in mice of both sexes<br />
Office of Environmental Health Hazard Assessment
4<br />
Environmental <strong>TNT</strong> Contamination and<br />
Leukemia in Germany<br />
Ecologic incidence rates study (Kolb et al., 1993)<br />
• Apparent cluster of myeloid leukemia in city of Stadtallendorf<br />
confirmed<br />
— AML men RR 3.5 (CI 1.4-8.5) 6 cases in city, 28 in unexposed county<br />
— AML women RR 3.2 (CI 1.4-7.2) 7 cases in city, 29 in unexposed county<br />
— CML men RR 9.1 (CI 3.5-23.4) 7 cases in city, 13 in unexposed county<br />
— CML women RR 1.3 (CI 0.2-10.3) 1 case in city, 10 in unexposed county<br />
Population-based case-control study (Kilian et al., 2001)<br />
• Increased risk found for one neighborhood<br />
— All leukemia OR 5.1 (CI 1.1-23.8) 4 cases, 3 controls exposed<br />
— CML only OR 9.0 (CI 1.1-72.1) 3 cases, 1 control exposed<br />
Office of Environmental Health Hazard Assessment
5<br />
<strong>TNT</strong>-Exposed Munitions Workers and<br />
Liver Cancer in China<br />
Historical cohort study (Yan et al., 2002)<br />
• Incidence compared to non-exposed workers:<br />
RR 3.46 (p < 0.01)<br />
• Mortality compared to Chinese national rates for cities:<br />
RR = 2.71 (p
6<br />
Case Reports of Liver Cancer and<br />
Leukemia in Workers Exposed to <strong>TNT</strong><br />
• Liver Cancer<br />
— 1 case in Garfinkel et al. 1988<br />
— 9 cases in references cited by Yan et al. 2002<br />
• Liu 1986 (4 cases)<br />
• Wang 1991 (3 cases)<br />
• Yang and Xie 1995 (1 case)<br />
• Fu and Shang 1998 (1 case)<br />
• Leukemia<br />
— 2 cases in references cited by Yan et al. 2002<br />
• Wang 1991 (1 case)<br />
• Liu et al. 1995 (1 case)<br />
Office of Environmental Health Hazard Assessment
7<br />
Tumors in Female F344 Rats Fed <strong>TNT</strong><br />
for Two Years (Furedi et al., 1984a)<br />
Urinary<br />
bladder<br />
Lesions<br />
<strong>TNT</strong> dose (mg/kg/day)<br />
0.0 0.4 2.0 10.0 50.0<br />
Papilloma 0/54 0/54 0/55 1/55 5/55* #<br />
Carcinoma 0/54 0/54 0/55 0/55 12/55** #<br />
Papilloma &<br />
carcinoma<br />
0/54 0/54 0/55 1/55 17/55** #<br />
* p
8<br />
Tumors in Female B6C3F1 Mice Fed <strong>TNT</strong><br />
for Two Years (Furedi et al., 1984b)<br />
Lesions<br />
leukemia/ malignant<br />
lymphoma of the spleen<br />
<strong>TNT</strong> dose (mg/kg/day)<br />
0.0 1.5 10.0 70.0<br />
** p
9<br />
Summary of Carcinogenicity<br />
Studies in Rodents<br />
• Rare urinary bladder carcinomas and papillomas<br />
in female F344 rats<br />
• Leukemia & malignant lymphomas of the spleen<br />
in female B6C3F1 mice<br />
• No treatment related tumors observed in male<br />
rats or male mice<br />
Office of Environmental Health Hazard Assessment
10<br />
Other Relevant Data<br />
• Pharmacokinetics & Metabolism<br />
• Genotoxicity<br />
• Structure Activity Comparisons with<br />
Proposition 65 Carcinogens<br />
Office of Environmental Health Hazard Assessment
11<br />
Pharmacokinetics & Metabolism of <strong>TNT</strong><br />
• Absorption: GI tract, skin & lungs<br />
• Distribution: Primarily to the liver, kidneys,<br />
lungs & fat<br />
• Elimination: Primarily via urinary excretion<br />
• Metabolism:<br />
-Nitroreduction of aromatic nitro groups to<br />
hydroxylamino derivatives<br />
-Oxidation of methyl group to benzyl alcohol &<br />
benzoic acid derivatives<br />
Office of Environmental Health Hazard Assessment
12<br />
Metabolism<br />
The major metabolic<br />
pathways of <strong>TNT</strong><br />
(adapted from Bolt et<br />
al., 2006).<br />
Office of Environmental Health Hazard Assessment
13<br />
<strong>TNT</strong> Genotoxicity : Bacterial Systems<br />
Salmonella typhimurium Reverse Mutation Assays<br />
•Positive in strains TA98, TA1537, TA1538<br />
& TA100<br />
-Frameshift & basepair substitution<br />
-Presence or absence of metabolic activation<br />
-Requires nitro reductase, o-acetyltransferase<br />
Escherichia coli SOS Chromotest<br />
•Positive (human placenta microsomal system)<br />
•Negative (rat liver S9)<br />
Office of Environmental Health Hazard Assessment
14<br />
<strong>TNT</strong> Genotoxicity: Mammalian In Vitro Systems<br />
• Rat<br />
—Negative: in vitro liver UDS assay<br />
• Mouse<br />
—Positive: P388 lymphoma TK locus mutation<br />
assay (-S9)<br />
• Hamster<br />
—Positive: CHO-HPRT mutation assay (+S9)<br />
—Negative: V79-HGPRT mutation assay<br />
Office of Environmental Health Hazard Assessment
15<br />
<strong>TNT</strong> Genotoxicity: Mammalian In Vivo Systems<br />
• Rat<br />
—Negative: liver UDS assay<br />
—Negative: bone marrow cytogenetic damage<br />
—Positive: oxidative DNA damage (8-oxodG) in<br />
sperm cells<br />
• Mouse<br />
—Negative: bone marrow micronucleus assay<br />
Office of Environmental Health Hazard Assessment
16<br />
<strong>TNT</strong> Genotoxicity in Humans<br />
• No difference between <strong>TNT</strong>-exposed and control<br />
workers in frequency of chromosomal aberrations<br />
(CA) in peripheral blood lymphocytes<br />
� Among <strong>TNT</strong>-exposed workers<br />
—Increased CA in NAT1 rapid vs. slow acetylator<br />
genotype<br />
� Among <strong>TNT</strong>-exposed workers with NAT1 rapid<br />
acetylator genotypes<br />
—Increased CA associated with GSTM1 null or<br />
GSTT1 null genotypes<br />
Office of Environmental Health Hazard Assessment
17<br />
Genotoxicity of <strong>TNT</strong> Metabolites<br />
2-ADNT 4-ADNT 2,4-DANT 2,6-DANT<br />
Salmonella mutation<br />
assays (TA 98, TA100) + + + +<br />
CHO-HPRT<br />
mutation assay<br />
V79-HGPRT<br />
mutation assay<br />
4-NHOH-DNT<br />
- + (S9) - + (weak)<br />
- + (weak) - -<br />
- Positive: in vitro oxidative DNA damage (8-oxodG);<br />
cleaves DNA at sites with consecutive guanines<br />
Office of Environmental Health Hazard Assessment
18<br />
Urine Mutagenicity<br />
• Rats treated with <strong>TNT</strong><br />
—Positive in Salmonella<br />
• Humans exposed to <strong>TNT</strong><br />
—Increased mutagenicity in Salmonella of<br />
urine from exposed as compared with<br />
unexposed controls<br />
—Higher in NAT1 rapid vs. slow acetylators<br />
Office of Environmental Health Hazard Assessment
Structure-Activity Comparisons<br />
with Proposition 65 listed carcinogens<br />
19<br />
2,6-Dinitrotoluene 2,4-Dinitrotoluene 2-Nitrotoluene<br />
Rats: liver (♂) Rats: skin (♂),<br />
liver & mammary (♀)<br />
Mice: kidney (♂)<br />
Rats: mammary, liver &<br />
lung (♂), mammary & liver<br />
(♀)<br />
Mice: intestinal (♂, ♀)<br />
DNA and protein binding DNA and protein binding DNA and protein binding<br />
Office of Environmental Health Hazard Assessment<br />
<strong>TNT</strong>
20<br />
Potential Mechanisms of<br />
Carcinogenicity<br />
• Genotoxicity<br />
- Mutation<br />
- Induction of oxidative DNA damage<br />
Office of Environmental Health Hazard Assessment
21<br />
Authoritative Body Reviews<br />
• US EPA (1993)<br />
—Reviewed animal studies by Furedi et al. (1984a,b)<br />
—Did not include any human studies<br />
—Did not include several studies on metabolism, genotoxicity,<br />
biomarkers of exposure<br />
—Group C: “possible human carcinogen”<br />
• IARC (1996)<br />
—Did not include the epidemiology studies of Kilian et al. (2001),<br />
Yan et al. (2002)<br />
—Did not include animal cancer studies<br />
—Did not include several recent studies on metabolism,<br />
genotoxicity, biomarkers of exposure<br />
—Group 3: “not classifiable as to carcinogenicity in<br />
humans”<br />
Office of Environmental Health Hazard Assessment
22<br />
<strong>TNT</strong>: Summary of Evidence<br />
• Humans<br />
—Not adequately studied<br />
—Suggestion from case reports and controlled<br />
studies of liver cancer & leukemia<br />
• Animals<br />
—Rare urinary bladder tumors in female rats<br />
—Leukemias/malignant lymphomas of the spleen<br />
in female mice<br />
• Other relevant evidence<br />
—Genotoxicity of <strong>TNT</strong> & its metabolites<br />
—Structural similarity to the carcinogens<br />
2-nitrotoluene, and 2,4- and 2,6-dinitrotoluene<br />
Office of Environmental Health Hazard Assessment